Clinical Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The Clinical Diagnostics Market is Segmented by Test (Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, and Other Tests), Product (Instruments, Reagents, and Other Products), End User (Hospital Laboratory, Diagnostic Laboratory, Point-of-care Testing, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The report offers values (in USD million) for the above segments.

Clinical Diagnostics Industry Overview

Clinical Diagnostics Market Summary
Study Period: 2018 - 2028
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 6.1 %

Major Players

Clinical Diagnostics Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Clinical Diagnostics Market Analysis

The clinical diagnostics market was valued at approximately USD 69,786.60 million in 2021, and it is expected to reach USD 99,051.77 million by 2027, registering a CAGR of 6.1% during the forecast period 2022-2027. The market is expected to grow due to the increasing incidence of infectious and chronic diseases and the increasing adoption of automated platforms.

Owing to the COVID-19 pandemic, there has been an increase in lab testing, which saw demand grow even more rapidly to keep pace with the suspected cases of COVID-19. According to the Atlantic Monthly Group, there was a tremendous increase globally in COVID-19 tests, rising from 760,441 tests in September 2020 to 964,792 new tests by October 2020. Thus, the rising number of tests owing to the constant upsurge in patients and funding by governments are the factors that are expected to escalate the demand for COVID-19 test kits and drive the overall market growth exponentially.

According to the Non-communicable Diseases Key Facts published by the World Health Organization (WHO), in April 2021, chronic diseases will kill around 41 million people each year, which is equivalent to 71% of all deaths worldwide. Owing to the increase in chronic diseases, the demand for healthcare systems is also increasing. Clinical diagnostics have, thus, proven to be beneficial in chronic disease conditions and are found to be valuable for disease prevention, detection, and management. Clinical diagnostics help detect early warning signs and individual risk factors, creating new opportunities for prevention and early intervention. Thus, the increasing incidence of chronic diseases is expected to propel the overall market further.

Clinical Diagnostics Industry Segments

As per the scope of the report, a clinical diagnostic test is a type of medical test performed to aid in the diagnosis or detection of any disease. These tests play a vital role in the prevention, control, and surveillance of any disease. Clinical diagnostics help in improving patient care, contributing to consumer safety, and reducing healthcare spending. The clinical diagnostics market is segmented by test (lipid panel​, liver panel​, renal panel​, complete blood count​, electrolyte testing, infectious disease testing,​ and other tests), product (instruments, reagents, and other products), end user (hospital laboratory​, diagnostic laboratory​, point-of-care testing,​ and other end users),​ and geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated sizes and trends for 17 countries across major regions globally. The report offers values (in USD million) for the above segments.

By Test
Lipid Panel
Liver Panel
Renal Panel
Complete Blood Count
Electrolyte Testing
Infectious Disease Testing
Other Tests
By Product
Other Products
By End User
Hospital Laboratory
Diagnostic Laboratory
Point-of-care Testing
Other End Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Clinical Diagnostics Market Trends

This section covers the major market trends shaping the Clinical Diagnostics Market according to our research experts:

Lipid Panel Tests Segment Expected to Register Good Growth in the Forecast Period

The lipid panel is a blood test that measures the lipids, fats, and fatty substances used as a source of energy by the body. The lipid panel includes tests for total cholesterol, HDL cholesterol, triglycerides, LDL cholesterol, cholesterol/HDL ratio, and non-HDL cholesterol.

Numerous studies have observed a decrease in total cholesterol, LDL-C, and HDL-C levels in patients with COVID-19 infections. Based on various studies, the decrease in LDL-C and/or HDL-C was more profound with greater severity of the illness. Therefore, patients with low HDL-C levels during admission to the hospital were at an increased risk of developing a severe disease compared to patients with high HDL-C levels, which has boosted the test demand. With the recovery from COVID-19, the serum lipid levels return to levels present before infection.

A lipid panel measures the level of specific lipids in blood to assess the risk of cardiovascular disease and is used in screening populations to identify subjects with a high risk of developing a cardiac event. According to Cardiovascular Diseases Key Facts published by the World Health Organization, in June 2021, cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for around 32% of all global deaths. Moreover, over three-quarters of CVD deaths take place in middle- and low-income countries. Hence, with an increase in the prevalence and mortality rate of cardiovascular diseases, there is an increase in the requirement of lipid profile testing at an early stage, which is driving the lipid panel segment.

Key companies are focusing on novel product developments and launches to leverage potential opportunities. Hence, the segment is estimated to grow over the forecast period due to the aforementioned factors.

Clinical Diagnostics Market: Incidence of New Cancer Cases (in million), by Cancer Type, Global, 2020

North America Expected to Dominate the Clinical Diagnostics Market Over the Forecast Period

The market for clinical diagnostics in the United States is majorly driven by the increasing geriatric population, rising patient awareness about the value of laboratory tests, and the rising prevalence of infectious and chronic disease patients.

The increasing number of COVID-19 infections has led to increased funding and an increasing number of testing, which has boosted the overall market growth. For instance, in September 2020, the National Institutes of Health, US, announced its plan to give funding of USD 129.3 million to nine companies, including MatMaCorp, Maxim Biomedical Inc., MicroGEM International, etc., to scale-up manufacturing support for a new set of COVID-19 testing technologies as part of its Rapid Acceleration of Diagnostics (RADx) initiative.

As per the Centers for Disease Control and Prevention (CDC), in the United States, four in ten adults have two or more chronic diseases, and six in ten adults have a chronic disease. Chronic diseases such as cancer, heart disease, and diabetes are the leading causes of death and disability in the United States and are leading drivers of the USD 3.8 trillion spent in annual health care costs. This has led to a higher demand for better treatment with efficient management, further driving the market in the United States. Hence, the increasing prevalence of infectious and chronic diseases and the growing awareness of the value of laboratory tests are expected to fuel the market growth in the country.

Clinical Diagnostics Market: Growth Rate by Region

Clinical Diagnostics Market Competitor Analysis

The market is highly competitive and consists of global and local players. The major key players in the market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, Qiagen, and Roche Diagnostics. The growing patient awareness and rising demand for high-quality care have made it imperative for healthcare providers to develop targeted therapies through specific and sensitive diagnostic tests. With the growing advances in clinical diagnostics, more companies are expected to penetrate the market in the coming future.

Clinical Diagnostics Market Top Players

  1. Bio-Rad Laboratories

  2. Danaher Corporation

  3. F. Hoffmann-La Roche AG

  4. Abbott Laboratories

  5. bioMérieux

*Disclaimer: Major Players sorted in no particular order

Clinical Diagnostics Market Concentration

Clinical Diagnostics Market Recent Developments

  • In January 2022, the Therapeutic Goods Administration (TGA) granted provisional approval for Novavax's COVID-19 vaccine branded as Nuvaxovid for use in Australia.
  • In September 2021, Ortho Clinical Diagnostics announced the availability of Immediate Spin Crossmatch (ISXM) on the company’s Ortho Vision and Ortho Vision Max Analyzers to aid in detecting incompatibility between recipients and donors in blood transfusions.

Clinical Diagnostics Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Infectious and Chronic Diseases​

      2. 4.2.2 Increasing Adoption of Automated Platforms

    3. 4.3 Market Restraints

      1. 4.3.1 Affordability for High-end Molecular Diagnostics

      2. 4.3.2 Limitations Associated with Reimbursement Scenario

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size in Value)

    1. 5.1 By Test

      1. 5.1.1 Lipid Panel

      2. 5.1.2 Liver Panel

      3. 5.1.3 Renal Panel

      4. 5.1.4 Complete Blood Count

      5. 5.1.5 Electrolyte Testing

      6. 5.1.6 Infectious Disease Testing

      7. 5.1.7 Other Tests

    2. 5.2 By Product

      1. 5.2.1 Instruments

      2. 5.2.2 Reagents

      3. 5.2.3 Other Products

    3. 5.3 By End User

      1. 5.3.1 Hospital Laboratory

      2. 5.3.2 Diagnostic Laboratory

      3. 5.3.3 Point-of-care Testing

      4. 5.3.4 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 BioMerieux

      4. 6.1.4 Bio-Rad Laboratories Inc.

      5. 6.1.5 Danaher Corporation

      6. 6.1.6 Siemens AG

      7. 6.1.7 Hologic Inc.

      8. 6.1.8 Qiagen NV

      9. 6.1.9 F. Hoffmann-La Roche AG

      10. 6.1.10 Thermo Fisher Scientific

      11. 6.1.11 Quest Diagnostics Inc.

      12. 6.1.12 Sysmex Corporation

      13. 6.1.13 Sonic Healthcare Ltd

      14. 6.1.14 Charles River Laboratories

    2. *List Not Exhaustive

**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Clinical Diagnostics Market Research FAQs

The Clinical Diagnostics Market is studied from 2018 - 2028.

The Clinical Diagnostics Market is growing at a CAGR of 6.1% over the next 5 years.

The Clinical Diagnostics Market is valued at 63305 Million USD in 2018.

The Clinical Diagnostics Market is valued at 93851 Million USD in 2028.

Asia-Pacific is growing at the highest CAGR over 2018 - 2028.

North America holds highest share in 2021.

Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche AG, Abbott Laboratories, bioMérieux are the major companies operating in Clinical Diagnostics Market.

Clinical Diagnostics Industry Reports

In-depth industry statistics and market share insights of the Clinical Diagnostics sector for 2020, 2021, and 2022. The Clinical Diagnostics research report provides a comprehensive outlook of the market size and an industry growth forecast for 2023 to 2028. Available to download is a free sample file of the Clinical Diagnostics report PDF.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!